Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Rimegepant NCT03461757 · Trial in Adult Subjects With Acute Migraines | Migraine | À vérifier | Phase 3 | COMPLETED | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:17 | Détail |
| Wristband with millimeter wave emission. NCT04568252 · MISTIC — Migraine STImulation Crisis of Migraine | Migraine | À vérifier | Non applicable | COMPLETED | Migraine is a neurovascular disease whose prevalence is estimated at almos… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:17 | Détail |
| CoolStat active device NCT04936061 · Transnasal Cooling for Migraine | Migraine | Traitement symptomatique | Non applicable | TERMINATED | This is a prospective, double-blind, sham-controlled, randomized study to… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:15 | Détail |
| Dihydroergotamine NCT04406649 · ASCEND — A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migr… | Migraine | À vérifier | Phase 3 | COMPLETED | Study STS101-007 is a randomized, double-blind, parallel group, placebo-co… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:15 | Détail |
| Dihydroergotamine NCT03901482 · EMERGE — A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101… | Migraine | À vérifier | Phase 3 | COMPLETED | Study STS101-007 is a randomized, double-blind, parallel group, placebo-co… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:15 | Détail |
| Levcromakalim NCT05889442 · COLLIDE — Effect of Levcromakalim in Individuals With Migraine Pretreated With E… | Migraine | À vérifier | Non applicable | COMPLETED | This study aims to explore the effect of Ivabradine on Levcromakalim-induc… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:15 | Détail |
| MLTM — Pilot Study for a Machine Learning Test for Migraine NCT05517200 · NCT05517200 | Migraine | Thérapie génique | À vérifier | UNKNOWN | This study is a single center, random participant selection, data analyst… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:15 | Détail |
| Sildenafil NCT05889455 · COMPETE — Effect of Sildenafil in Individuals With Migraine Pretreated With Eren… | Migraine | À vérifier | Non applicable | COMPLETED | This study is done to evaluate whether treatment with the drug sildenafil… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:15 | Détail |
| sumatriptan nasal powder NCT03338920 · Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatme… | Migraine | À vérifier | Phase 3 | TERMINATED | This study will be conducted to evaluate the safety and efficacy of sumatr… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:15 | Détail |
| Anisodine Hydrobromide NCT05416476 · ATEM — Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine | Migraine | À vérifier | Phase 3 | UNKNOWN | In this study,288 adult migraine patients aged 18-65 years (diagnosed with… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| Dihydroergotamine NCT04940390 · SUMMIT — A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to… | Migraine | À vérifier | Phase 3 | COMPLETED | Study STS101-007 is a randomized, double-blind, parallel group, placebo-co… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| Fremanezumab Prefilled Syringe NCT06244823 · The FreMRI Study: Advanced MRI on Migraine Patients Treated With Fremanezumab | Migraine | À vérifier | Phase 4 | UNKNOWN | The goal of this open-label, single-blind, controlled-trial is to evaluate… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| Low-Dose Naltrexone and Acetaminophen Combination NCT03194555 · The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen… | Migraine | À vérifier | Phase 2 | COMPLETED | The Preventive Treatment of Migraine with Low-Dose Naltrexone and Acetamin… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| Migraine With Aura and Patent Foramen Ovale: Identification of Biomar… NCT06046508 · NCT06046508 | Migraine | Traitement symptomatique | À vérifier | UNKNOWN | This is a multicenter prospective observational study aimed to asses wheth… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| Mindfulness and Mechanisms of Pain Processing in Adults With Migraines NCT02695498 · NCT02695498 | Migraine | Traitement symptomatique | Non applicable | COMPLETED | Although many adults with migraines use non-pharmacological treatment opti… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| Naltrexone and Acetaminophen NCT06245902 · ANODYNE-1 — An Acute Migraine Factorial Study | Migraine | À vérifier | Phase 2 | COMPLETED | The study consists of a screening visit, out-patient treatment of a modera… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| patent foramen ovale closure NCT03521193 · LEARNER — pLatelEts And MigRaine iN patEnt foRamen Ovale | Migraine | Traitement symptomatique | Non applicable | COMPLETED | Migraine is a common, chronic neurovascular disorder characterized by atta… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| Patients with migraine treated with triptans, Lasmiditan or Gepants NCT06267664 · Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP) | Migraine | Ralentissement de la progression · Traitement symptomatique · Thérapie génique | À vérifier | UNKNOWN | Migraine is the third most prevalent disease and the leading reason of yea… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| Riociguat (BAY 63-2521) NCT05750446 · Effect of Riocigaut on Migraine Attack Induction in People With Migraine | Migraine | À vérifier | Non applicable | COMPLETED | This double-blind, randomized, placebo-controlled cross-over clinical tria… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
| rizatriptan NCT00894556 · A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment o… | Migraine | À vérifier | Phase 3 | COMPLETED | A study to provide evidence supporting the benefit of Rizatriptan in patie… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:14 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Current treatment for erectile dysfunction: an umbrella review of sys… Acupuncture · PMID 41792626 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source This umbrella review aimed to summarize and provide a general evaluation of the effectiveness of current treatments for… | The aging male : the official journal of the Internati… 2026-08-16 19:21:40 | Source |
| Rotation-traction manipulation versus cervical traction for axial nec… Acupuncture · PMID 42464813 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Axial neck pain is a common manifestation of cervical degenerative disc disease (CDD). Rotation-traction manipulation (… | The Libyan journal of medicine 2026-08-16 19:21:40 | Source |
| Forecasting migraine with time-series machine learning from mobile he… PREDI-CRISIS — Migraine Attack Pain Phase Prediction Study · PMID 41913100 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Machine learning provides a powerful framework to model the complex patterns underlying migraine attack onset from real… | The journal of headache and pain 2026-08-16 19:21:37 | Source |
| Waning light, waxing pain: The lunar cycle's association with migrain… PREDI-CRISIS — Migraine Attack Pain Phase Prediction Study · PMID 40874381 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To examine circalunar rhythms in migraine headache occurrence in a prospective cohort of 98 adults with episodic migrai… | Headache 2026-08-16 19:21:37 | Source |
| Voltage-gated sodium channels in the nervous system: Molecular physio… ETX101 · PMID 40808385 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Voltage-gated sodium channels are essential ionic-conductance pathways in the nervous system, which play an irreplaceab… | Neural regeneration research 2026-08-16 18:25:58 | Source |
| Pressure-induced suppression of supramolecular dynamics in hydrogen-b… Memantine · PMID 42447528 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Determining how pressure and temperature compete to govern supramolecular organization in hydrogen-bonded liquids remai… | Spectrochimica acta. Part A, Molecular and biomolecula… 2026-08-16 13:43:00 | Source |
| The multivariate genetic architecture of psychiatric and insulin resi… Memantine · PMID 42435748 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Psychiatric disorders frequently co-occur with insulin resistance (IR)-related conditions, including obesity, type 2 di… | European neuropsychopharmacology : the journal of the… 2026-08-16 13:43:00 | Source |
| Treatment of animal models of Alzheimer's disease with extracellular… Memantine · PMID 41622480 | Migraine | Ralentissement de la progression · Immunomodulation · Traitement symptomatique… | Publication | PubMed | Voir la publication source Alzheimer's disease is a complex and devastating neurodegenerative disorder that accounts for roughly 80% of all dement… | Neural regeneration research 2026-08-16 13:43:00 | Source |
| Comparison between Perineural and Intravenous Dexamethasone on Durati… Lidocaine Hydrochloride · PMID 41574836 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source A disadvantage of regional blocks is their limited period of efficacy. One of the medications that has been found to ha… | Annals of African medicine 2026-08-16 13:25:53 | Source |
| Topical delivery of Lidocaine using spicules for local anesthesia. Lidocaine Hydrochloride · PMID 41402578 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Topical anesthesia offers a painless alternative to injections but is limited by the low skin permeability of local ane… | Drug delivery and translational research 2026-08-16 13:25:53 | Source |
| Ibuprofen vs. acetaminophen for acute mild-to-moderate pain managemen… Acetaminophen/Paracetamol · PMID 42448615 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source The purpose of this study is to compare the safety of ibuprofen and acetaminophen (paracetamol) for acute mild-to-moder… | British journal of clinical pharmacology 2026-08-16 13:21:32 | Source |
| Safety of acetylcysteine: a scoping review of iatrogenic overdose cas… Acetaminophen/Paracetamol · PMID 42370551 | Migraine | Ralentissement de la progression | Publication | PubMed | Voir la publication source Acetylcysteine is the standard antidote for acetaminophen (paracetamol) toxicity and is widely considered safe when adm… | Clinical toxicology (Philadelphia, Pa.) 2026-08-16 13:21:32 | Source |
| Transcranial Magnetic Stimulation for the Treatment of Chemo Brain. Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases · PMID… | Migraine | À vérifier | Publication | PubMed | Voir la publication source This pilot feasibility study aimed to evaluate the effects of transcranial magnetic stimulation (TMS) on chemotherapy-r… | Sensors (Basel, Switzerland) 2026-08-16 13:17:50 | Source |
| Effect of Adding Erector Spinae Plane Block to a Multimodal Analgesic… Sham Procedure · PMID 42604369 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Available evidence regarding the effect of erector spinae plane block (ESPB) as a component of multimodal analgesia on… | Journal of pain research 2026-08-16 13:12:04 | Source |
| Long-term outcomes of genicular artery embolization for knee osteoart… Sham Procedure · PMID 42009866 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To determine if genicular artery embolization (GAE) is more effective in relieving pain symptoms after 12 months compar… | European radiology 2026-08-16 13:12:04 | Source |
| Aspirin protects trophoblast function against hypoxia-induced oxidati… Aspirin (acetylsalicylic acid) · PMID 42241790 | Migraine | Neuroprotection · Immunomodulation · Thérapie génique | Publication | PubMed | Voir la publication source Preeclampsia (PE, a pregnancy-specific hypertensive disorder) is characterized by placental hypoxia, oxidative stress,… | Reproductive biology 2026-08-16 13:12:02 | Source |
| Acoustic Coupling for Double-Blind Human Low-Intensity Focused Ultras… sham device · PMID 42115110 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Low-intensity focused ultrasound (LIFU) is a non-invasive neuromodulation technique with the potential for precise targ… | Ultrasound in medicine & biology 2026-08-16 13:12:01 | Source |
| Clinical Efficacy of Pulsed Electromagnetic Field Therapy on Thumb Ca… sham device · PMID 41015912 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Thumb carpometacarpal (CMC) osteoarthritis (OA) is a common source of hand pain with limited nonoperative treatment opt… | Hand (New York, N.Y.) 2026-08-16 13:12:01 | Source |
| Current research hotspots and difficulties of chronic prostatitis/chr… Calcitonin Gene-Related Peptide · PMID 41555741 | Migraine | Immunomodulation · Traitement symptomatique | Publication | PubMed | Voir la publication source Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) presents a significant clinical challenge in urology. Tradit… | Annals of medicine 2026-08-16 13:11:59 | Source |
| A case of repetitive myocardial infarction with unobstructed coronari… MR-angiography, GTN · PMID 31449602 | Migraine | Ralentissement de la progression · Traitement symptomatique | Publication | PubMed | Voir la publication source Myocardial infarction is most commonly caused by thrombosis occurring on a background of coronary atherosclerosis, resu… | European heart journal. Case reports 2026-08-16 13:11:58 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |